# Shared Decision Making for Antipsychotic Medications

> **NCT05416658** · NA · NOT_YET_RECRUITING · sponsor: **New York State Psychiatric Institute** · enrollment: 120 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorders
- Delusional Disorder
- Other Specified Schizophrenia Spectrum and Other Psychotic Disorder

## Interventions

- **OTHER:** The Antipsychotic Medication Decision Aid (APM-DA)

## Key facts

- **NCT ID:** NCT05416658
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05416658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05416658, "Shared Decision Making for Antipsychotic Medications". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05416658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*